Publications

Export 27 results:
Auteur Title Type [ Année(Asc)]
Filtres: Mot-clé is Schizophrenia  [Enlever les filtres]
2020
Paquin V, Lemire M, King S.  2020.  Ecosystem approaches to the risk for schizophrenia.. Schizophr Res. 220:278-280.
2019
M Chakravarty M.  2019.  Guest editorial: Special issue on machine learning in schizophrenia.. Schizophr Res. 214:1-2.
2016
Merner N, d'Arc BForgeot, Bell SC, Maussion G, Peng H, Gauthier J, Crapper L, Hamdan FF, Michaud JL, Mottron L et al..  2016.  A de novo frameshift mutation in chromodomain helicase DNA-binding domain 8 (CHD8): A case report and literature review.. Am J Med Genet A. 170A(5):1225-35.
Hannon E, Spiers H, Viana J, Pidsley R, Burrage J, Murphy TM, Troakes C, Turecki G, O'Donovan MC, Schalkwyk LC et al..  2016.  Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci.. Nat Neurosci. 19(1):48-54.
2015
Baldwin CH, Srivastava LK.  2015.  Can the neurodevelopmental theory account for sex differences in schizophrenia across the life span? J Psychiatry Neurosci. 40(2):75-7.
Bhardwaj SK, Stojkovic K, Kiessling S, Srivastava LK, Cermakian N.  2015.  Constant light uncovers behavioral effects of a mutation in the schizophrenia risk gene Dtnbp1 in mice.. Behav Brain Res. 284:58-68.
Keshavan MS, Mehta UMeherwan, Padmanabhan JL, Shah JL.  2015.  Dysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions.. Dev Psychopathol. 27(2):615-35.
Wheeler AL, Wessa M, Szeszko PR, Foussias G, M Chakravarty M, Lerch JP, DeRosse P, Remington G, Mulsant BH, Linke J et al..  2015.  Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis.. JAMA Psychiatry. 72(5):446-55.
Gerretsen P, Menon M, M Chakravarty M, Lerch JP, Mamo DC, Remington G, Pollock BG, Graff-Guerrero A.  2015.  Illness denial in schizophrenia spectrum disorders: a function of left hemisphere dominance.. Hum Brain Mapp. 36(1):213-25.
Girard SL, Dion PA, Bourassa CV, Geoffroy S, Lachance-Touchette P, Barhdadi A, Langlois M, Joober R, Krebs M-O, Dubé M-P et al..  2015.  Mutation burden of rare variants in schizophrenia candidate genes.. PLoS One. 10(6):e0128988.
Behdinan T, Foussias G, Wheeler AL, Stefanik L, Felsky D, Remington G, Rajji TK, M Chakravarty M, Voineskos AN.  2015.  Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up.. Schizophr Res. 169(1-3):69-75.
Shah JL, Tandon N, Howard ER, Mermon D, Miewald JM, Montrose DM, Keshavan MS.  2015.  Pituitary volume and clinical trajectory in young relatives at risk for schizophrenia.. Psychol Med. 45(13):2813-24.
Whitley R, Palmer V, Gunn J.  2015.  Recovery from severe mental illness.. CMAJ. 187(13):951-2.
Lepage M, Hawco C, Bodnar M.  2015.  Relational Memory as a Possible Neurocognitive Marker of Schizophrenia.. JAMA Psychiatry. 72(9):946-7.
Lal S, Malla A.  2015.  Service Engagement in First-Episode Psychosis: Current Issues and Future Directions.. Can J Psychiatry. 60(8):341-5.
M Chakravarty M, Rapoport JL, Giedd JN, Raznahan A, Shaw P, D Collins L, Lerch JP, Gogtay N.  2015.  Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: a longitudinal study.. Hum Brain Mapp. 36(4):1458-69.
Haro JMaria, Altamura C, Corral R, Elkis H, Evans J, Malla A, Krebs M-O, Zink M, Bernasconi C, Lalonde J et al..  2015.  Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study.. Schizophr Res. 169(1-3):234-40.
2014
Roy L, Crocker AG, Nicholls TL, Latimer E, Ayllon AReyes.  2014.  Criminal behavior and victimization among homeless individuals with severe mental illness: a systematic review.. Psychiatr Serv. 65(6):739-50.
Wheeler AL, M Chakravarty M, Lerch JP, Pipitone J, Daskalakis ZJ, Rajji TK, Mulsant BH, Voineskos AN.  2014.  Disrupted prefrontal interhemispheric structural coupling in schizophrenia related to working memory performance.. Schizophr Bull. 40(4):914-24.
Plitman E, Nakajima S, de la Fuente-Sandoval C, Gerretsen P, M Chakravarty M, Kobylianskii J, Chung JKu, Caravaggio F, Iwata Y, Remington G et al..  2014.  Glutamate-mediated excitotoxicity in schizophrenia: a review.. Eur Neuropsychopharmacol. 24(10):1591-605.
Whitley R.  2014.  Introducing recovery.. Can J Psychiatry. 59(5):233-5.
Pidsley R, Viana J, Hannon E, Spiers H, Troakes C, Al-Saraj S, Mechawar N, Turecki G, Schalkwyk LC, Bray NJ et al..  2014.  Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia.. Genome Biol. 15(10):483.
Richard-Devantoy S, Orsat M, Dumais A, Turecki G, Jollant F.  2014.  Neurocognitive vulnerability: suicidal and homicidal behaviours in patients with schizophrenia.. Can J Psychiatry. 59(1):18-25.
Malla A.  2014.  The role of cognition in outcome in schizophrenia and related disorders.. Can J Psychiatry. 59(1):3-4.
Latimer E, Naidu A, Moodie EEM, Clark RE, Malla A, Tamblyn R, Wynant W.  2014.  Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.. Psychiatr Serv. 65(10):1210-7.

Pages